SharpLink Gaming Announces Second Quarter 2024 Financial Results
August 15, 2024 08:30 ET
|
SharpLink Gaming, Inc.
MINNEAPOLIS, Aug. 15, 2024 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), an online performance-based marketing company serving the U.S. sports betting and...
Odysight.ai Reports Financial Results for the First Half of 2024 and Provides Business Update
August 15, 2024 08:30 ET
|
Odysight.ai Inc.
OMER, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a leading provider of visual based predictive maintenance (PdM) and condition-based monitoring (CBM) solutions,...
Digihost Announces 57% Increase in Quarterly-YOY Revenue for Q2 2024 and $8M EBITDA* for YTD 2024
August 15, 2024 06:00 ET
|
Digihost Technology Inc.
HOUSTON, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq / TSXV: DGHI), an innovative U.S. based blockchain technology and computer infrastructure...
CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024 21:00 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis today reported financial results for the quarter ended June 30, 2024, and provided a business update.
Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 14, 2024 16:30 ET
|
Biofrontera Inc.
Woburn, MA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today...
Fundamental Global Inc. Reports Second Quarter 2024 Financial Results
August 14, 2024 16:15 ET
|
Fundamental Global Inc.
Mooresville, NC, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGF, FGPP) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc. (“FG Financial”),...
GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 14, 2024 16:05 ET
|
GT Biopharma, Inc.
GTB-3650 TriKE® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025GTB-5550 TriKE® IND submission for treatment of B7H3 positive solid tumors expected in 1H...
Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update
August 14, 2024 16:01 ET
|
Celcuity Inc.
Announced plan to initiate Phase 3 VIKTORIA-2 trial evaluating gedatolisib combined with fulvestrant plus a CDK4/6 inhibitor as first-line treatment for patients with HR+, HER2- advanced breast...
Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024 16:00 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis today reported financial results for the quarter ended June 30, 2024, and provided a business update.
Digital Brands Group to Report Second Quarter 2024 Financial Results on Monday, August 19, 2024
August 14, 2024 10:00 ET
|
Digital Brands Group, Inc.
Austin, TX, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (“DBG”) (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands, will report financial results for the...